o-acyltransferase

Nevanimibe hydrochloride (PD-132301 hydrochloride) 是一种口服有效的，选择性酰基辅酶 A：胆固醇 O-酰基转移酶 1 抑制剂，EC50为 9 nM。它抑制 ACAT2，EC50为 368 nM。它诱导细胞凋亡，具有抗肾上腺皮质癌的潜力。

OSMI-1 是一种 O-GlcNAc 转移酶 (OGT) 抑制剂 (IC50=2.7 μM)，具有口服活性和细胞渗透性。OSMI-1 可以抑制蛋白质 O-GlcNA 酰化，而不会定性地改变细胞表面 N- 或 O- 连接的聚糖。

CL 277082 (Ddpmhu) 是一种酰基辅酶A：胆固醇O-酰基转移酶抑制剂，抑制肉芽肿组织 ACAT 活性。

Ezetimibe (SCH 58235) 是一种膳食胆固醇吸收抑制剂。它是一种NPC1L1抑制剂，是有效的Nrf2激活剂。

GOAT-IN-1 is an inhibitor of ghrelin O-acyltransferase (GOAT), which could be useful for the prophylaxis or treatment of diabetes, hyperlipidemia, non-alcoholic fatty liver, Alzheimer’s disease, Parkinson’s disease, cerebrovascular dementia, cerebral infa

Nevanimibe is an orally active and selective inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) (EC50 of 9 nM).

Pyripyropene A is a potent and selective inhibitor of sterol O-acyltransferase 2 (SOAT2) acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2)(IC50 of 0.07 µM).

DGAT1-IN-1是 DGAT1的高效抑制剂，在 Hep3B 细胞过表达 DGAT1裂解物中，测得IC50低于10nM。

FR-190809 is a nonadrenotoxic and orally efficacious inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT) (IC50: 45 nM).

Desmethyl nevanimibe (Compound 5) 是 Nevanimibe (PD-132301) 的去甲基化合物，作为固醇 O-酰基转移酶 1 (SOAT1) 的抑制剂。

FR-186054 is a new, potent inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT) and has oral activity. Compared to other ACAT inhibitors, this compound displayed excellent in vitro efficacy, irrespective of dosing method, indicating superior charact

ALN29882 is a glycerolipid, that is located at the plasma membrane. It is made up of two fatty acid chains that are covalently attached to a single glycerol molecule with the help of an ester linkage. 18:1 DG has been used as a diacyl-glycerol source in diacylglycerol O-acyltransferase 1 (DGAT1) assay. It has also been used as substrate to assess compounds as potential inhibitors of DGAT-1 in DGAT-1 enzyme assay. It is suitable to use in lipid-protein overlay screen assay with the recombinant protein His-AtROP6.

PF-07202954为一种弱碱性DGAT2抑制剂，其对人类DGAT2的IC50值为10 nM。在西方饮食喂养的大鼠模型中，PF-07202954能有效降低肝脏内的甘油三酯含量。

RP-64477 是有效的胆固醇酯化酶酰基辅酶 A：胆固醇 O-酰基转移酶 (ACAT) 抑制剂。

OGT-IN-2 是 OGT 抑制剂，抑制 sOGT 和 ncOGT 的 IC50分别为 30 μM 和 53 μM。它在关节疾病方面有研究的价值，如关节软骨疾病、骨关节炎。

1,2-Di-O-(9Z-octadecenyl)-sn-glycero-3-phosphocholine是一种表面活性剂，具有增强脂质体形成的作用。它在研究神经酰胺和磷酸神经酰胺的生物效应方面表现出有效性。此外，在卵磷脂-胆固醇酰基转移酶的磷脂酶A活性测定中显示出重要应用，尤其是在醚基质中。

Aphadilactone C shows significant antimalarial activity with the IC50 value of 170 ± 10 nM. It shows potent and selective inhibition against the diacylglycerol O-acyltransferase-1 (DGAT-1) enzyme (IC50 = 0.46 ± 0.09 uM, selectivity index > 217).

Yakuchinone B 是一种酰基辅酶 A：胆固醇 O-酰基转移酶 (ACAT) 的抑制剂，具有降低胆固醇的作用，源自姜科 (Zingiberaceae) 的种子。其对于大鼠肝脏ACAT的IC50值为20.6 μM。Yakuchinone B 被认为在高胆固醇血症和动脉粥样硬化的研究中具有潜力。